Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...
For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.
The weight loss drug market is bracing itself for a transformative year in 2026, with significant changes anticipated for GLP ...
The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
MedPage Today on MSN
GLP-1 agents showed broader risks, rewards in 2025
Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...
Oprah Winfrey has finally answered the question everyone has been asking. After a year of speculation regarding her ...
A recent study revealed that popular GLP-1 weight-loss drugs may significantly minimise severe asthma attacks among teenagers ...
Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...
Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...
The Centers for Medicare & Medicaid Services late last year introduced the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) Model to expand access to select ...
Oprah Winfrey detailed that in addition to weight loss and renewed energy, her use of GLP-1 medications for weight loss also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results